News & Articles

Testing at the point-of-care improves patient care with results in less than a minute

Ultrasensitive Simoa technology to advance research into tumor-derived exosomes at the University of Pittsburgh Cancer Institute

The SCIEX Citrine™ MS/MS medical device provides clinical labs with one solution to tackle today’s difficult assays, and the versatility to address tomorrow’s precision medicine and wellness testing

Ralph McDade explains the importance of using ultra-sensitive immunoassays from Quanterix

Bonnie Howell, Executive Director at Merck, discusses the use of ultrasensitive Quanterix technology to develop novel therapies for HIV and shares her hopes for a future world, free of the disease

Read exclusive interviews from experts in healthcare settings around the world, to discover how mass spectrometry is improving clinical diagnostics

Henrik Zetterberg discusses the use of ultrasensitive biomarker assays from Quanterix for Alzheimer’s research

Gyrolab Generic TK Kit for early-stage biotherapeutic development

Stanford researchers have developed a reliable, hassle-free HIV test ideal for screen large numbers of people and heading off potential outbreaks

New test to identify IBS sufferers who respond to diet restrictions

Comprehensive immune profiling & monitoring

Study demonstrates that the test can add prognostic information on overall survival

New blood test identifies 12 metabolic sub-types of autism spectrum disorder

Next-generation mass spectrometry-based solution analyzes dried blood spots from newborn babies to test for wide range of metabolic disorders

New blood test provides a unique new framework for early detection of the most common cancers

Study by the University of Bonn shows that even after a change to a healthy diet, the body's defenses remain hyperactive

Research by the University of Edinburgh suggests a way to detect the cause of stroke